Company Filing History:
Years Active: 2019-2023
Title: Grégory Meiffren: Innovator in Injectable Solutions
Introduction
Grégory Meiffren is a notable inventor based in Meyzieu, France. He has made significant contributions to the field of injectable solutions, particularly involving human glucagon. With a total of two patents to his name, Meiffren's work is paving the way for advancements in medical treatments.
Latest Patents
Meiffren's latest patents include compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid. The first patent describes an injectable aqueous solution with a pH ranging from 6.0 to 8.0, which includes human glucagon and a co-polyamino acid that bears carboxylate charges and hydrophobic radicals. Additionally, this composition may also contain a gastrointestinal hormone. The second patent focuses on physically stable compositions in a similar injectable form, also with a pH of 6.0 to 8.0, incorporating human glucagon and a statistical co-polyamino acid, along with the potential inclusion of a gastrointestinal hormone.
Career Highlights
Grégory Meiffren is currently associated with Adocia, a company known for its innovative approaches in biotechnology. His work at Adocia has allowed him to explore and develop new formulations that enhance the stability and efficacy of injectable solutions.
Collaborations
Meiffren collaborates with talented individuals such as Alexandre Geissler and Olivier Soula. Their combined expertise contributes to the innovative projects at Adocia, fostering a collaborative environment that encourages groundbreaking research.
Conclusion
Grégory Meiffren's contributions to the field of injectable solutions highlight his role as an influential inventor. His patents reflect a commitment to advancing medical treatments through innovative formulations.